Direct publisher rights
Every entitlement maps to an agreement with the publisher whose content is covered. Rights are never inferred from another publisher’s agreement.
For AI labs / buy side
License publisher content with verifiable access.
DataLicenser helps an AI lab reach direct terms with a publisher, then supplies the identity, access, structured-delivery, and telemetry layer needed to operate the agreement.
Sales-assisted access
Lab onboarding is not self-serve. Business identity, permitted use, publisher coverage, delivery format, and commercial terms are reviewed together.
Contact lab partnershipsVerified technical identity
Supported source-IP verification and signed credentials distinguish authorized access from a spoofed user-agent string.
Structured delivery
Receive covered content as clean Markdown or JSON without advertising chrome or unrelated layout markup.
Audit-ready telemetry
Publisher, content, license, decision, time, and usage references form a reconcilable event trail.
Exclusive access
A defined commercial advantage.
Where exclusivity is part of the publisher agreement, DataLicenser restricts the licensed route to the authorized lab for the covered scope and term.
Non-exclusive access
Separate state for every buyer.
A publisher can authorize multiple labs under different terms. Each lab receives distinct credentials, measurement, and revocation state.
Integration shape
Verified identity in. Licensed content out.
01Verify
Business and technical identity are reviewed before credentials are issued.
02Agree
Lab and publisher approve content scope, use, term, price, and exclusivity.
03Access
Source signals and signed credentials are checked against the live entitlement.
04Reconcile
Usage events support audit, billing, and renewal discussions for that publisher agreement.
DataLicenser charges the AI lab a separate platform and access-orchestration fee under the lab-side agreement.
Lab business development
Discuss publisher fit, permitted use, and delivery requirements.
Publisher availability and rights are confirmed directly. We do not claim coverage, exclusivity, or pricing that is not under active agreement.
Start a lab conversation